In the normal pancreas specimen, no -SMA-positive PSCs (activated myofibroblast-like cells) were seen, however, GFAP-positive quiescent PSCs showed low expression of the GLP-1R (Figures 1 eg)
GLP-1RAs significantly reduced HbA1c (MD: -1.13), weight (MD: -2.12) and FPG (MD: -31.44) levels as first-line therapy compared to placebo
Its crucial to understand that such modifications are not part of FDA-approved labeling for branded medications like Ozempic or Wegovy and should be approached with extreme caution, always guided by medical expertise
Frequently Asked Questions How long will I need to take the medication
Studies have shown reduction in heart disease, diabetes, dementia, fatty liver, sleep apnea, asthma, addiction, and more
When the prior authorization packet doesnt document that step therapy requirements were attempted or that the patient is clinically exempt, the payer denies the PA or requests additional documentation